SCHECHTER JONATHAN
SEC Form 4 insider trading activity
SCHECHTER JONATHAN has filed 5 SEC Form 4 filings (8 transaction rows) across 2 companies, including PMCB, OBLG, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jan 7, 2026.
On the most recent filing, SCHECHTER JONATHAN is listed as Director at PharmaCyte Biotech, Inc. Inside the rolling window, SCHECHTER JONATHAN reported 4 open-market purchases totaling $67K in PMCB and OBLG and no open-market sales. The largest disclosed transaction in the window is a purchase of 10,000 OBLG shares on Nov 14, 2025, worth $19K.
Companies traded
Other insiders at PMCB
Insider Buying
$67K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has SCHECHTER JONATHAN made?
SCHECHTER JONATHAN has filed 5 SEC Form 4 filings (8 transaction rows) across 2 companies, including PMCB, OBLG since 2025.
Which companies does SCHECHTER JONATHAN trade?
SCHECHTER JONATHAN has filed SEC Form 4 disclosures for 2 companies, including PMCB, OBLG.
When was SCHECHTER JONATHAN's most recent SEC Form 4 filing?
SCHECHTER JONATHAN's most recent SEC Form 4 filing on Tracefour is dated Jan 7, 2026.
What is SCHECHTER JONATHAN's total buy and sell value in the current window?
Inside the rolling retention window, SCHECHTER JONATHAN bought $67K and sold $0 based on SEC Form 4 filings.
What was SCHECHTER JONATHAN's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 OBLG shares on 2025-11-14, worth $19K, per SEC Form 4 filings.